Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 85 entries
Sorted by: Best Match Show Resources per page
Cardiovascular pharmacology: new drugs and new indications.

Current opinion in anaesthesiology

Ahmed AB, Latimer RD, Vuylsteke A.
PMID: 17016273
Curr Opin Anaesthesiol. 2000 Feb;13(1):5-13. doi: 10.1097/00001503-200002000-00002.

This review presents a brief overview of some of the many exciting developments that are taking place in the field of cardiovascular pharmacology. Research continues to progress at a rapid rate, and we can expect many drugs to enter...

Cite
Ahmed AB, Latimer RD, Vuylsteke A. Cardiovascular pharmacology: new drugs and new indications. Curr Opin Anaesthesiol. 2000;13(1):5-13doi: 10.1097/00001503-200002000-00002.
Ahmed, A. B., Latimer, R. D., & Vuylsteke, A. (2000). Cardiovascular pharmacology: new drugs and new indications. Current opinion in anaesthesiology, 13(1), 5-13. https://doi.org/10.1097/00001503-200002000-00002
Ahmed, A B, et al. "Cardiovascular pharmacology: new drugs and new indications." Current opinion in anaesthesiology vol. 13,1 (2000): 5-13. doi: https://doi.org/10.1097/00001503-200002000-00002
Ahmed AB, Latimer RD, Vuylsteke A. Cardiovascular pharmacology: new drugs and new indications. Curr Opin Anaesthesiol. 2000 Feb;13(1):5-13. doi: 10.1097/00001503-200002000-00002. PMID: 17016273.
Copy Download .nbib Format: NLM
Acute Normovolaemic Haemodilution and Cardiac Surgery - current opinion and controversies.

Annals of cardiac anaesthesia

Leonard IE, Vuylsteke A.
PMID: 17848767
Ann Card Anaesth. 2000 Jul;3(2):19-24.

No abstract available.

Cite
Leonard IE, Vuylsteke A. Acute Normovolaemic Haemodilution and Cardiac Surgery - current opinion and controversies. Ann Card Anaesth. 2000;3(2):19-24
Leonard, I. E., & Vuylsteke, A. (2000). Acute Normovolaemic Haemodilution and Cardiac Surgery - current opinion and controversies. Annals of cardiac anaesthesia, 3(2), 19-24.
Leonard, I E, and Vuylsteke, A. "Acute Normovolaemic Haemodilution and Cardiac Surgery - current opinion and controversies." Annals of cardiac anaesthesia vol. 3,2 (2000): 19-24.
Leonard IE, Vuylsteke A. Acute Normovolaemic Haemodilution and Cardiac Surgery - current opinion and controversies. Ann Card Anaesth. 2000 Jul;3(2):19-24. PMID: 17848767.
Copy Download .nbib Format: NLM
Gene therapy in the management of cardiovascular diseases.

Annals of cardiac anaesthesia

Mulavisala P, Vuylsteke A, Latimer R.
PMID: 17851154
Ann Card Anaesth. 2001 Jan;4(1):4-6.

Gene therapy is about to create a revolution in the available methods to limit and correct many of the common disease processes involving the heart. Since the human genome was published in draft form a year ago there has...

Cite
Mulavisala P, Vuylsteke A, Latimer R. Gene therapy in the management of cardiovascular diseases. Ann Card Anaesth. 2001;4(1):4-6
Mulavisala, P., Vuylsteke, A., & Latimer, R. (2001). Gene therapy in the management of cardiovascular diseases. Annals of cardiac anaesthesia, 4(1), 4-6.
Mulavisala, P, et al. "Gene therapy in the management of cardiovascular diseases." Annals of cardiac anaesthesia vol. 4,1 (2001): 4-6.
Mulavisala P, Vuylsteke A, Latimer R. Gene therapy in the management of cardiovascular diseases. Ann Card Anaesth. 2001 Jan;4(1):4-6. PMID: 17851154.
Copy Download .nbib Format: NLM
A comparison of the inotropic effects of milrinone and piroximone.

Annals of cardiac anaesthesia

Latimer MD, Callingham BA, Vuylsteke A.
PMID: 17851157
Ann Card Anaesth. 2001 Jan;4(1):17-20.

Patients with low cardiac output syndrome often have a reduced sensitivity to inotropes acting via the beta-adrenergic receptors. In this situation, drugs such as milrinone and piroximone may have a therapeutic advantage. Strips of human right atrial appendage were...

Cite
Latimer MD, Callingham BA, Vuylsteke A. A comparison of the inotropic effects of milrinone and piroximone. Ann Card Anaesth. 2001;4(1):17-20
Latimer, M. D., Callingham, B. A., & Vuylsteke, A. (2001). A comparison of the inotropic effects of milrinone and piroximone. Annals of cardiac anaesthesia, 4(1), 17-20.
Latimer, M D, et al. "A comparison of the inotropic effects of milrinone and piroximone." Annals of cardiac anaesthesia vol. 4,1 (2001): 17-20.
Latimer MD, Callingham BA, Vuylsteke A. A comparison of the inotropic effects of milrinone and piroximone. Ann Card Anaesth. 2001 Jan;4(1):17-20. PMID: 17851157.
Copy Download .nbib Format: NLM
The Arabidopsis thaliana Transcription Factor AtMYB102 Functions in Defense Against the Insect Herbivore Pieris rapae.

Plant signaling & behavior

De Vos M, Denekamp M, Dicke M, Vuylsteke M, Van Loon L, Smeekens SC, Pieterse CM.
PMID: 19517001
Plant Signal Behav. 2006 Nov;1(6):305-11. doi: 10.4161/psb.1.6.3512.

In Arabidopsis thaliana the R2R3-MYB transcription factor family consists of over 100 members and is implicated in many biological processes, such as plant development, metabolism, senescence, and defense. The R2R3-MYB transcription factor gene AtMYB102 has been shown to respond...

Cite
De Vos M, Denekamp M, Dicke M, et al. The Arabidopsis thaliana Transcription Factor AtMYB102 Functions in Defense Against the Insect Herbivore Pieris rapae. Plant Signal Behav. 2006;1(6):305-11doi: 10.4161/psb.1.6.3512.
De Vos, M., Denekamp, M., Dicke, M., Vuylsteke, M., Van Loon, L., Smeekens, S. C., & Pieterse, C. M. (2006). The Arabidopsis thaliana Transcription Factor AtMYB102 Functions in Defense Against the Insect Herbivore Pieris rapae. Plant signaling & behavior, 1(6), 305-11. https://doi.org/10.4161/psb.1.6.3512
De Vos, Martin, et al. "The Arabidopsis thaliana Transcription Factor AtMYB102 Functions in Defense Against the Insect Herbivore Pieris rapae." Plant signaling & behavior vol. 1,6 (2006): 305-11. doi: https://doi.org/10.4161/psb.1.6.3512
De Vos M, Denekamp M, Dicke M, Vuylsteke M, Van Loon L, Smeekens SC, Pieterse CM. The Arabidopsis thaliana Transcription Factor AtMYB102 Functions in Defense Against the Insect Herbivore Pieris rapae. Plant Signal Behav. 2006 Nov;1(6):305-11. doi: 10.4161/psb.1.6.3512. PMID: 19517001; PMCID: PMC2634245.
Copy Download .nbib Format: NLM
Prediction of testcross means and variances among F3 progenies of F1 crosses from testcross means and genetic distances of their parents in maize.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik

Melchinger AE, Gumber RK, Leipert RB, Vuylsteke M, Kuiper M.
PMID: 24710890
Theor Appl Genet. 1998 Mar;96(3):503-12. doi: 10.1007/s001220050767.

Prediction of the means and genetic variances in segregating generations could help to assess the breeding potential of base populations. In this study, we investigated whether the testcross (TC) means and variances of F3 progenies from F1 crosses in...

Cite
Melchinger AE, Gumber RK, Leipert RB, et al. Prediction of testcross means and variances among F3 progenies of F1 crosses from testcross means and genetic distances of their parents in maize. Theor Appl Genet. 1998;96(3):503-12doi: 10.1007/s001220050767.
Melchinger, A. E., Gumber, R. K., Leipert, R. B., Vuylsteke, M., & Kuiper, M. (1998). Prediction of testcross means and variances among F3 progenies of F1 crosses from testcross means and genetic distances of their parents in maize. TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 96(3), 503-12. https://doi.org/10.1007/s001220050767
Melchinger, A E, et al. "Prediction of testcross means and variances among F3 progenies of F1 crosses from testcross means and genetic distances of their parents in maize." TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik vol. 96,3 (1998): 503-12. doi: https://doi.org/10.1007/s001220050767
Melchinger AE, Gumber RK, Leipert RB, Vuylsteke M, Kuiper M. Prediction of testcross means and variances among F3 progenies of F1 crosses from testcross means and genetic distances of their parents in maize. Theor Appl Genet. 1998 Mar;96(3):503-12. doi: 10.1007/s001220050767. PMID: 24710890.
Copy Download .nbib Format: NLM
Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol.

JMIR research protocols

De Baetselier I, Reyniers T, Nöstlinger C, Wouters K, Fransen K, Crucitti T, Kenyon C, Buyze J, Schurmans C, Laga M, Vuylsteke B.
PMID: 28135199
JMIR Res Protoc. 2017 Jan 30;6(1):e11. doi: 10.2196/resprot.6767.

BACKGROUND: Pre-exposure prophylaxis (PrEP) is a promising and effective tool to prevent HIV. With the approval of Truvada as daily PrEP by the European Commission in August 2016, individual European Member states prepare themselves for PrEP implementation following the...

Cite
De Baetselier I, Reyniers T, Nöstlinger C, et al. Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol. JMIR Res Protoc. 2017;6(1):e11doi: 10.2196/resprot.6767.
De Baetselier, I., Reyniers, T., Nöstlinger, C., Wouters, K., Fransen, K., Crucitti, T., Kenyon, C., Buyze, J., Schurmans, C., Laga, M., Vuylsteke, B. (2017). Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol. JMIR research protocols, 6(1), e11. https://doi.org/10.2196/resprot.6767
De Baetselier, Irith, et al. "Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol." JMIR research protocols vol. 6,1 (2017): e11. doi: https://doi.org/10.2196/resprot.6767
De Baetselier I, Reyniers T, Nöstlinger C, Wouters K, Fransen K, Crucitti T, Kenyon C, Buyze J, Schurmans C, Laga M, Vuylsteke B. Pre-Exposure Prophylaxis (PrEP) as an Additional Tool for HIV Prevention Among Men Who Have Sex With Men in Belgium: The Be-PrEP-ared Study Protocol. JMIR Res Protoc. 2017 Jan 30;6(1):e11. doi: 10.2196/resprot.6767. PMID: 28135199; PMCID: PMC5306610.
Copy Download .nbib Format: NLM
Alternative therapies in controlling oral malodour: a systematic review.

Journal of breath research

Wylleman A, Vuylsteke F, Dekeyser C, Teughels W, Quirynen M, Laleman I.
PMID: 33227726
J Breath Res. 2021 Jan 22;15(2). doi: 10.1088/1752-7163/abcd2b.

Is there a role for alternative therapies in controlling intra-oral halitosis? Treatments other than tongue cleaning and anti-halitosis products containing zinc, chlorhexidine and cetylpyridinium chloride were considered as alternative therapies. Four databases were searched (PubMed, EMBASE, Web of Science...

Cite
Wylleman A, Vuylsteke F, Dekeyser C, et al. Alternative therapies in controlling oral malodour: a systematic review. J Breath Res. 2021;15(2)doi: 10.1088/1752-7163/abcd2b.
Wylleman, A., Vuylsteke, F., Dekeyser, C., Teughels, W., Quirynen, M., & Laleman, I. (2021). Alternative therapies in controlling oral malodour: a systematic review. Journal of breath research, 15(2), . https://doi.org/10.1088/1752-7163/abcd2b
Wylleman, A, et al. "Alternative therapies in controlling oral malodour: a systematic review." Journal of breath research vol. 15,2 (2021). doi: https://doi.org/10.1088/1752-7163/abcd2b
Wylleman A, Vuylsteke F, Dekeyser C, Teughels W, Quirynen M, Laleman I. Alternative therapies in controlling oral malodour: a systematic review. J Breath Res. 2021 Jan 22;15(2). doi: 10.1088/1752-7163/abcd2b. PMID: 33227726.
Copy Download .nbib Format: NLM
Alternative therapies in controlling oral malodour: a systematic review.

Journal of breath research

Wylleman A, Vuylsteke F, Dekeyser C, Teughels W, Quirynen M, Laleman I.
PMID: 33227726
J Breath Res. 2021 Jan 22;15(2). doi: 10.1088/1752-7163/abcd2b.

Is there a role for alternative therapies in controlling intra-oral halitosis? Treatments other than tongue cleaning and anti-halitosis products containing zinc, chlorhexidine and cetylpyridinium chloride were considered as alternative therapies. Four databases were searched (PubMed, EMBASE, Web of Science...

Cite
Wylleman A, Vuylsteke F, Dekeyser C, et al. Alternative therapies in controlling oral malodour: a systematic review. J Breath Res. 2021;15(2)doi: 10.1088/1752-7163/abcd2b.
Wylleman, A., Vuylsteke, F., Dekeyser, C., Teughels, W., Quirynen, M., & Laleman, I. (2021). Alternative therapies in controlling oral malodour: a systematic review. Journal of breath research, 15(2), . https://doi.org/10.1088/1752-7163/abcd2b
Wylleman, A, et al. "Alternative therapies in controlling oral malodour: a systematic review." Journal of breath research vol. 15,2 (2021). doi: https://doi.org/10.1088/1752-7163/abcd2b
Wylleman A, Vuylsteke F, Dekeyser C, Teughels W, Quirynen M, Laleman I. Alternative therapies in controlling oral malodour: a systematic review. J Breath Res. 2021 Jan 22;15(2). doi: 10.1088/1752-7163/abcd2b. PMID: 33227726.
Copy Download .nbib Format: NLM
Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study).

Annals of surgery

Blok RD, Sharabiany S, Stoker J, Laan ETM, Bosker RJI, Burger JWA, Chaudhri S, van Duijvendijk P, van Etten B, van Geloven AAW, de Graaf EJR, Hoff C, Hompes R, Leijtens JWA, Rothbarth J, Rutten HJT, Singh B, Vuylsteke RJCLM, de Wilt JHW, Dijkgraaf MGW, Bemelman WA, Musters GD, Tanis PJ.
PMID: 33534231
Ann Surg. 2022 Jan 01;275(1):e37-e44. doi: 10.1097/SLA.0000000000004763.

OBJECTIVE: To determine long-term outcomes of a randomized trial (BIOPEX) comparing biological mesh and primary perineal closure in rectal cancer patients after extralevator abdominoperineal resection and preoperative radiotherapy, with a primary focus on symptomatic perineal hernia.SUMMARY BACKGROUND DATA: BIOPEX...

Cite
Blok RD, Sharabiany S, Stoker J, et al. Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Ann Surg. 2022;275(1):e37-e44doi: 10.1097/SLA.0000000000004763.
Blok, R. D., Sharabiany, S., Stoker, J., Laan, E. T. M., Bosker, R. J. I., Burger, J. W. A., Chaudhri, S., van Duijvendijk, P., van Etten, B., van Geloven, A. A. W., de Graaf, E. J. R., Hoff, C., Hompes, R., Leijtens, J. W. A., Rothbarth, J., Rutten, H. J. T., Singh, B., Vuylsteke, R. J. C. L. M., de Wilt, J. H. W., Dijkgraaf, M. G. W., Bemelman, W. A., Musters, G. D., & Tanis, P. J. (2022). Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Annals of surgery, 275(1), e37-e44. https://doi.org/10.1097/SLA.0000000000004763
Blok, Robin D, et al. "Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study)." Annals of surgery vol. 275,1 (2022): e37-e44. doi: https://doi.org/10.1097/SLA.0000000000004763
Blok RD, Sharabiany S, Stoker J, Laan ETM, Bosker RJI, Burger JWA, Chaudhri S, van Duijvendijk P, van Etten B, van Geloven AAW, de Graaf EJR, Hoff C, Hompes R, Leijtens JWA, Rothbarth J, Rutten HJT, Singh B, Vuylsteke RJCLM, de Wilt JHW, Dijkgraaf MGW, Bemelman WA, Musters GD, Tanis PJ. Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Ann Surg. 2022 Jan 01;275(1):e37-e44. doi: 10.1097/SLA.0000000000004763. PMID: 33534231.
Copy Download .nbib Format: NLM
Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study).

Annals of surgery

Blok RD, Sharabiany S, Stoker J, Laan ETM, Bosker RJI, Burger JWA, Chaudhri S, van Duijvendijk P, van Etten B, van Geloven AAW, de Graaf EJR, Hoff C, Hompes R, Leijtens JWA, Rothbarth J, Rutten HJT, Singh B, Vuylsteke RJCLM, de Wilt JHW, Dijkgraaf MGW, Bemelman WA, Musters GD, Tanis PJ.
PMID: 33534231
Ann Surg. 2022 Jan 01;275(1):e37-e44. doi: 10.1097/SLA.0000000000004763.

OBJECTIVE: To determine long-term outcomes of a randomized trial (BIOPEX) comparing biological mesh and primary perineal closure in rectal cancer patients after extralevator abdominoperineal resection and preoperative radiotherapy, with a primary focus on symptomatic perineal hernia.SUMMARY BACKGROUND DATA: BIOPEX...

Cite
Blok RD, Sharabiany S, Stoker J, et al. Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Ann Surg. 2022;275(1):e37-e44doi: 10.1097/SLA.0000000000004763.
Blok, R. D., Sharabiany, S., Stoker, J., Laan, E. T. M., Bosker, R. J. I., Burger, J. W. A., Chaudhri, S., van Duijvendijk, P., van Etten, B., van Geloven, A. A. W., de Graaf, E. J. R., Hoff, C., Hompes, R., Leijtens, J. W. A., Rothbarth, J., Rutten, H. J. T., Singh, B., Vuylsteke, R. J. C. L. M., de Wilt, J. H. W., Dijkgraaf, M. G. W., Bemelman, W. A., Musters, G. D., & Tanis, P. J. (2022). Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Annals of surgery, 275(1), e37-e44. https://doi.org/10.1097/SLA.0000000000004763
Blok, Robin D, et al. "Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study)." Annals of surgery vol. 275,1 (2022): e37-e44. doi: https://doi.org/10.1097/SLA.0000000000004763
Blok RD, Sharabiany S, Stoker J, Laan ETM, Bosker RJI, Burger JWA, Chaudhri S, van Duijvendijk P, van Etten B, van Geloven AAW, de Graaf EJR, Hoff C, Hompes R, Leijtens JWA, Rothbarth J, Rutten HJT, Singh B, Vuylsteke RJCLM, de Wilt JHW, Dijkgraaf MGW, Bemelman WA, Musters GD, Tanis PJ. Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study). Ann Surg. 2022 Jan 01;275(1):e37-e44. doi: 10.1097/SLA.0000000000004763. PMID: 33534231.
Copy Download .nbib Format: NLM
Hair and nail nicotine levels of mothers and their infants as valid biomarkers of exposure to intrauterine tobacco smoke.

Tobacco induced diseases

Go MD, Al-Delaimy WK, Schilling D, Vuylsteke B, Mehess S, Spindel ER, McEvoy CT.
PMID: 35035343
Tob Induc Dis. 2021 Dec 22;19:100. doi: 10.18332/tid/143209. eCollection 2021.

INTRODUCTION: Tobacco use remains the single most modifiable cause of adverse pregnancy outcomes. It is crucial to be able to accurately quantify the burden of tobacco exposure on both the mother and fetus to have better measures of efficacy...

Cite
Go MD, Al-Delaimy WK, Schilling D, et al. Hair and nail nicotine levels of mothers and their infants as valid biomarkers of exposure to intrauterine tobacco smoke. Tob Induc Dis. 2021;19:100doi: 10.18332/tid/143209.
Go, M. D., Al-Delaimy, W. K., Schilling, D., Vuylsteke, B., Mehess, S., Spindel, E. R., & McEvoy, C. T. (2021). Hair and nail nicotine levels of mothers and their infants as valid biomarkers of exposure to intrauterine tobacco smoke. Tobacco induced diseases, 19100. https://doi.org/10.18332/tid/143209
Go, Mitzi D, et al. "Hair and nail nicotine levels of mothers and their infants as valid biomarkers of exposure to intrauterine tobacco smoke." Tobacco induced diseases vol. 19 (2021): 100. doi: https://doi.org/10.18332/tid/143209
Go MD, Al-Delaimy WK, Schilling D, Vuylsteke B, Mehess S, Spindel ER, McEvoy CT. Hair and nail nicotine levels of mothers and their infants as valid biomarkers of exposure to intrauterine tobacco smoke. Tob Induc Dis. 2021 Dec 22;19:100. doi: 10.18332/tid/143209. eCollection 2021. PMID: 35035343; PMCID: PMC8693083.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 85 entries